121 related articles for article (PubMed ID: 35856796)
1. Response to Sriwijitalai and Wiwanitkit re "The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study".
Rayati Damavandi A; Fathi F; Eskandari N
Viral Immunol; 2022 Jul; ():. PubMed ID: 35856796
[No Abstract] [Full Text] [Related]
2. Re: "The Association of Programmed Death 1 Gene Polymorphisms of PD1.3 G/A and PD1.5 C/T with Risk of COVID-19 in an Iranian Population: A Case-Control Study" by Rayati Damavandi
Sriwijitalai W; Wiwanitkit V
Viral Immunol; 2022 Jul; ():. PubMed ID: 35856833
[No Abstract] [Full Text] [Related]
3. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
Fathi F; Sadeghi E; Lotfi N; Hafezi H; Ahmadi M; Mozafarpoor S; Motedayyen H
Int J Immunogenet; 2020 Feb; 47(1):57-64. PubMed ID: 31565862
[TBL] [Abstract][Full Text] [Related]
4. Association of programmed death-1 gene polymorphisms with the risk of basal cell carcinoma.
Fathi F; Ebrahimi M; Eslami A; Hafezi H; Eskandari N; Motedayyen H
Int J Immunogenet; 2019 Dec; 46(6):444-450. PubMed ID: 31293069
[TBL] [Abstract][Full Text] [Related]
5. Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients.
Tahoori MT; Pourfathollah AA; Akhlaghi M; Daneshmandi S; Nicknam MH; Soleimanifar N
Clin Exp Rheumatol; 2011; 29(5):763-7. PubMed ID: 21961966
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of genetic polymorphisms in programmed cell death 1. Associations with rheumatoid arthritis, ankylosing spondylitis, and type 1 diabetes susceptibility.
Lee YH; Bae SC; Kim JH; Song GG
Z Rheumatol; 2015 Apr; 74(3):230-9. PubMed ID: 24942602
[TBL] [Abstract][Full Text] [Related]
7. Association between PDCD1 gene polymorphisms and psoriasis susceptibility in the Chinese population.
Hua S; Fan B; Mao W; Xu R; Wang Y; Kuai L; Ding X; Li B; Chen J; Miao X
Int J Dermatol; 2021 Nov; 60(11):1411-1417. PubMed ID: 34057203
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk.
Gao J; Gai N; Wang L; Liu K; Liu XH; Wei LT; Tian T; Li SL; Zheng Y; Deng YJ; Dai ZJ; Fu RG
Oncotarget; 2017 May; 8(22):36885-36897. PubMed ID: 28415570
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death 1 gene polymorphism as a possible risk for systemic lupus erythematosus in Egyptian females.
Abo El-Khair SM; Sameer W; Awadallah N; Shaalan D
Lupus; 2019 Oct; 28(12):1427-1434. PubMed ID: 31551030
[TBL] [Abstract][Full Text] [Related]
10. Association between PDCD1 Gene Polymorphisms and Risk of Systemic Lupus Erythematosus in Three Main Ethnic Groups of the Malaysian Population.
Chua KH; Lian LH; Sim XJ; Cheah TE; Lau TP
Int J Mol Sci; 2015 Apr; 16(5):9794-803. PubMed ID: 25938972
[TBL] [Abstract][Full Text] [Related]
11. Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection.
Zhang G; Li Z; Han Q; Li N; Zhu Q; Li F; Lv Y; Chen J; Lou S; Liu Z
Infect Genet Evol; 2011 Oct; 11(7):1624-30. PubMed ID: 21712100
[TBL] [Abstract][Full Text] [Related]
12.
Parakh S; Musafer A; Paessler S; Witkowski T; Suen CSNLW; Tutuka CSA; Carlino MS; Menzies AM; Scolyer RA; Cebon J; Dobrovic A; Long GV; Klein O; Behren A
Front Immunol; 2021; 12():672521. PubMed ID: 34177913
[TBL] [Abstract][Full Text] [Related]
13. PDCD1 gene polymorphisms as regulators of T-lymphocyte activity in cutaneous melanoma risk and prognosis.
Gomez GVB; Rinck-Junior JA; Oliveira C; Silva DHL; Mamoni RL; Lourenço GJ; Moraes AM; Lima CSP
Pigment Cell Melanoma Res; 2018 Mar; 31(2):308-317. PubMed ID: 29090522
[TBL] [Abstract][Full Text] [Related]
14. Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus.
Velázquez-Cruz R; Orozco L; Espinosa-Rosales F; Carreño-Manjarrez R; Solís-Vallejo E; López-Lara ND; Ruiz-López IK; Rodríguez-Lozano AL; Estrada-Gil JK; Jiménez-Sánchez G; Baca V
Eur J Hum Genet; 2007 Mar; 15(3):336-41. PubMed ID: 17228327
[TBL] [Abstract][Full Text] [Related]
15. Programmed cell death 1 (PDCD1) gene haplotypes and susceptibility of patients to basal cell carcinoma.
Fathi F; Zamani B; Piroozmand A; Mozafarpoor S; Seyedhashemi E; ArefNezhad R; Motedayyen H
Mol Biol Rep; 2021 Mar; 48(3):2047-2052. PubMed ID: 33389528
[TBL] [Abstract][Full Text] [Related]
16.
Kawabata M; Inoue N; Watanabe M; Kobayashi A; Hidaka Y; Miyauchi A; Iwatani Y
Autoimmunity; 2021 Nov; 54(7):450-459. PubMed ID: 34494503
[TBL] [Abstract][Full Text] [Related]
17. The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors.
Boutros A; Carosio R; Campanella D; Spagnolo F; Banelli B; Morabito A; Pistillo MP; Croce E; Cecchi F; Pronzato P; Queirolo P; Raposio E; Fontana V; Tanda ET
Immunooncol Technol; 2023 Dec; 20():100408. PubMed ID: 38192613
[TBL] [Abstract][Full Text] [Related]
18. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of programmed cell death 1 gene (PDCD1) polymorphisms with susceptibility to chronic urticaria in patients with positive autologous serum skin test.
Brzoza Z; Grzeszczak W; Trautsolt W; Moczulski D
J Investig Allergol Clin Immunol; 2012; 22(6):432-6. PubMed ID: 23101188
[TBL] [Abstract][Full Text] [Related]
20. Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients.
Namavar Jahromi F; Samadi M; Mojtahedi Z; Haghshenas MR; Taghipour M; Erfani N
Immunol Invest; 2017 Jul; 46(5):469-480. PubMed ID: 28535114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
